statistiche ricercatore

CAMPIOTTI, LEONARDO

Distribuzione geografica

Continente	#
NA - Nord America	7.125
EU - Europa	3.681
AS - Asia	2.334
SA - Sud America	353
Continente sconosciuto - Info sul continente non disponibili	166
AF - Africa	47
OC - Oceania	4
Totale	13.710

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	7.002
IT - Italia	1.899
SG - Singapore	844
CN - Cina	509
UA - Ucraina	404
VN - Vietnam	377
SE - Svezia	321
BR - Brasile	288
DE - Germania	267
HK - Hong Kong	259
FR - Francia	183
IE - Irlanda	142
TR - Turchia	141
GB - Regno Unito	124
RU - Federazione Russa	89
FI - Finlandia	69
IN - India	55
NL - Olanda	55
MX - Messico	53
BD - Bangladesh	48
CA - Canada	45
AR - Argentina	23
PL - Polonia	23
JP - Giappone	22
ES - Italia	21
AT - Austria	19
BE - Belgio	19
ZA - Sudafrica	16
EC - Ecuador	14
IQ - Iraq	12
CR - Costa Rica	10
NG - Nigeria	10
SA - Arabia Saudita	9
MD - Moldavia	8
LT - Lituania	7
PE - Perù	7
PK - Pakistan	7
VE - Venezuela	7
ID - Indonesia	6
JO - Giordania	6
MA - Marocco	6
CL - Cile	5
CO - Colombia	5
PT - Portogallo	5
UZ - Uzbekistan	5
EU - Europa	4
KE - Kenya	4
PH - Filippine	4
AE - Emirati Arabi Uniti	3
AI - Anguilla	3
AU - Australia	3
BO - Bolivia	3
CH - Svizzera	3
DZ - Algeria	3
GR - Grecia	3
HN - Honduras	3
JM - Giamaica	3
KZ - Kazakistan	3
MK - Macedonia	3
MY - Malesia	3
QA - Qatar	3
RO - Romania	3
AM - Armenia	2
AZ - Azerbaigian	2
BG - Bulgaria	2
CZ - Repubblica Ceca	2
EG - Egitto	2
ET - Etiopia	2
HU - Ungheria	2
IL - Israele	2
IR - Iran	2
LK - Sri Lanka	2
RS - Serbia	2
SV - El Salvador	2
TH - Thailandia	2
TN - Tunisia	2
BA - Bosnia-Erzegovina	1
BY - Bielorussia	1
CY - Cipro	1
DK - Danimarca	1
GP - Guadalupe	1
KN - Saint Kitts e Nevis	1
LB - Libano	1
LU - Lussemburgo	1
ME - Montenegro	1
MN - Mongolia	1
NO - Norvegia	1
NP - Nepal	1
NR - Nauru	1
PR - Porto Rico	1
PS - Palestinian Territory	1
PY - Paraguay	1
SC - Seychelles	1
SN - Senegal	1
TT - Trinidad e Tobago	1
TW - Taiwan	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	13.549

Salva come PNG Salva come JPEG

Città	#
Milan	1.063
Fairfield	816
Ashburn	605
San Jose	550
Singapore	468
Chandler	440
Woodbridge	414
Houston	345
Seattle	327
Jacksonville	319
Wilmington	319
Cambridge	260
Hong Kong	256
Ann Arbor	210
Dallas	209
Dearborn	180
Nyköping	178
Beijing	162
Princeton	156
Dublin	141
Council Bluffs	130
New York	114
Como	109
Boardman	101
Dong Ket	85
Rome	83
The Dalles	82
Ho Chi Minh City	78
Lauterbourg	75
Chicago	70
Izmir	59
San Diego	59
Los Angeles	54
Santa Clara	54
Munich	50
Kocaeli	44
Hanoi	41
Mexico City	40
Redmond	37
Orem	36
Frankfurt am Main	33
London	33
Ogden	31
São Paulo	28
Helsinki	26
San Mateo	25
Chennai	22
Tokyo	20
Brussels	17
Brooklyn	16
Manchester	16
Warsaw	16
Guangzhou	15
Kunming	14
Nuremberg	14
Phoenix	14
Amsterdam	13
Johannesburg	13
Montreal	13
Toronto	13
Atlanta	12
Denver	12
Hefei	12
Redwood City	12
Stockholm	12
Buffalo	11
Haiphong	11
Nanjing	11
Norwalk	11
Washington	11
Abuja	10
Bologna	10
Boston	10
Genoa	10
Mumbai	10
Turku	10
Belo Horizonte	9
Falkenstein	9
Rio de Janeiro	9
San Francisco	9
Shanghai	9
Varese	9
Da Nang	8
Vienna	8
Cavaria con Premezzo	7
Hangzhou	7
New Delhi	7
Philadelphia	7
San José	7
Verona	7
Ankara	6
Berlin	6
Dhaka	6
Guayaquil	6
Las Vegas	6
Nanchang	6
Pune	6
Baghdad	5
Brasília	5
Caxias do Sul	5
Totale	9.555

Salva come PNG Salva come JPEG

Nome	#
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both	408
Final Results of Northern Italy Leukemia Group (NILG) Trial 10/07 Combining Pediatric-Type Therapy with Minimal Residual Disease Study and Risk-Oriented Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia (ALL)	280
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment	275
Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells	247
PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis	242
Right ventricular remodelling in mild hypertensive patients: role of left ventricular morpho-functional parameters	226
Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis	219
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML	213
ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations—comment	211
Acute myeloid leukemia with associated translocation t(15;17) and 11q23/MLL abnormality	209
A particular case of AML patient with the polymorphism G105G (rs11554137) and the missense mutation R132C in IDH1 gene	208
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia	204
JAK2, 46/1 haplotype and chronic myelogenous leukemia: diagnostic and therapeutic potential	204
Primary extranodal diffuse large B-cell lymphomas: Many sites, many entities? Clinico-pathological, immunohistochemical and cytogenetic study of 106 cases	204
Clinical Impact of an Accurate Genetic Characterization of Older Acute Myeloid Leukemia Patients: A Report from the Northern Italy Leukemia Group (NILG) Randomized Trial 02/06	197
Bone marrow necrosis related to imatinib mesylate therapy for cml bilineal blast crisis	196
In vitro effects of Apixaban on 5 different cancer cell lines	196
sRAGE and early signs of cardiac target organ damage in mild hypertensives	196
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register	195
Fatal Splenic Rupture in a Previously Undiagnosed Multiple Myeloma: Morphological, Immunophenotypical and Molecular Cytogenetic Analyses	195
Assessing residual disease in imatinib-treated CML patients by DNA compared to MRNA assays	192
JAK2 mutation and atypical chronic myeloid leukemia	190
JAK2-V617F mutation and Philadelphia positive chronic myeloid leukemia.	189
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.	188
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub	187
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients	186
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia	185
A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study).	184
Vitamin D and tyrosine kinase inhibitors in chronic myeloid leukemia	180
Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia	179
Imatinib (IM) discontinuation in chronic myeloid leukemia (CML): A pharmacogenetic score for patients with durable complete molecular response (CMR)	179
Tirosine kinase inhibitors adverse events	177
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register	172
Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia	168
Baseline PET as prognostic index in diffuse large B-cell lymphoma and grade IIIb follicular lymphoma: a retrospective study of a single-centre experience	159
Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people	157
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards	155
Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study	154
Megakaryocytic blast crisis as first presentation of chronic myeloid leukemia	154
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry	153
What changed in the Italian internal medicine and geriatric wards during the lockdown	152
Metabolic tumour volume and response to therapy in diffuse large B cell lymphoma	150
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients	149
Caspofungin Primary Antifungal Prophylaxis in Acute Leukemia Patients During Induction Therapy: Results of a Prospective Phase II Multicentric Study (ProfilC Study)	147
Molecular monitoring of residual disease in chronic myeloid leukemia by genomic DNA compared with conventional mRNA analysis.	145
Negative impact of high body mass index on cetuximab-mediated cellular cytotoxicity against human colon carcinoma cells	140
Clinical features, treatment and outcome of patients with low-grade gastric MALT lymphoma: a single centre experience	139
Prevention of anthracycline-induced cardiotoxicity: a systematic review and meta-analysis	137
Current management of cancer-associated venous thromboembolism in patients with thrombocytopenia: a retrospective cohort study	135
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients	134
Pain and Frailty in Hospitalized Older Adults	133
Identification of a Chromatin-Splicing Mutational Signature to Define Secondary Acute Myeloid Leukemia: A Report from the Northern Italy Leukemia Group (NILG) Prospective Trial 02/06	130
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06	129
Comment on low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study	129
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry	128
Primary non-Hodgkin's lymphoma of the kidney: A case report	127
IN ADULT ACUTE MYELOID LEUKAEMIA (AML) ALL RISK SUBSETS BENEFIT FROM A SEQUENTIAL HIGH-DOSE PROGRAMME AS EARLY RESCUE OF FIRST INDUCTION FAILURE: A REPORT FROM NORTHERN ITALY LEUKAEMIA GROUP (NILG)	126
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia	125
Composite follicular lymphoma and “early” (in situ and mantle zone growth pattern) mantle cell neoplasia: A rare entity with peculiar cytogenetic and clinical features	124
Antibiotic use and associated factors in a large sample of hospitalised older people	123
CEOP 1-8 regimen for treatment of intermediate-high grade non-Hodgkin's lymphoma in elderly patients	121
Tyrosin-Kinase Inhibitors Discontinuation in Patients with Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis	121
High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG)	120
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients	119
Primary testicular non-Hodgkin lymphomas. A clinicopathologic study of nine cases	116
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: analysis of the REPOSI registry	116
Subacute demyelinating polyneuropathy associated with B-cell lymphoma and IgM antibodies against myelin-associated glycoprotein responsive to rituximab	113
TWO-STEP RESPONSE-ORIENTED INDUCTION PREDICTS LONG-TERM OUTCOME OF ADULT PATIENTS WITH STANDARD- AND HIGH-RISK ACUTE MYELOID LEUKAEMIA (AML): A NORTHERN ITALY LEUKAEMIA GROUP (NILG) STUDY	112
NEXT GENERATION SEQUENCING (NGS) CONFIRMED THE ADVERSE CLINICAL IMPACT OF RUNX1 MUTATIONS IN A SUBSET OF ACUTE MYELOID LEUKEMIA NORMAL KARYOTYPE PATIENTS NEGATIVE FOR RISK DEFINING GENES MUTATIONS AND HOMOGENOUSLY TREATED WITHIN A CLINICAL TRIAL (NILG AML 02/06)	111
Evaluation of international prognostic factors project for patients with advanced Hodgkin's disease: A single centre experience	109
MOLECULAR PROLIFE BY NEXT GENERATION SEQUENCING OF ACUTE MYELOID LEUKEMIA WITH NORMAL KARYOTYPE: CLINICAL RESULTS FROM THE PROSPECTIVE TRIAL 02/06 OF THE NORTHERN ITALY LEUKEMIA GROUP (NILG)	107
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register)	107
Association of ARA-C, mitoxantrone and etoposide in elderly affected by acute myeloid leucemia	104
CLINICAL SIGNIFICANCE OF END OF INDUCTION MINIMAL RESIDUAL DISEASE IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION AFTER A SINGLE CHEMOTHERAPY COURSE	104
PROGNOSTIC VALUE OF CLONAL HEMATOPOIESIS-MUTATIONS DETECTED AT DIAGNOSIS IN ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE	96
Primary gastric lymphomas. Clinico-pathological study and evaluation of prognostic factors in 65 cases treated surgically	94
Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients	92
Post-Treatment Residual Disease Detection by Droplet Digital PCR in Hairy Cell Leukemia: Comparison with Allele Specific PCR and Immunohistochemistry	91
Association of hairy cell leucemia (HCL) with low-grade non Hodgkin lymphoma (NHL) successfully treated with retuximab. A case report	88
Body mass index (BMI) influence on Cetuximab-induced antibody-dependent cellular cytotoxicity in advanced colon cancer	83
Low efficacy of thalidomide in improving response after induction in myeloma patients candidate to high-dose therapy	81
Correction to: Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register	79
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study	79
High frequency of BCL2 gene rearrangement-negative follicular lymphoma in northwestern Italy	77
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register	76
Multicentric castleman disease with splenic presentation: report of two rare cases with focus on histopathological features and review of the literature	73
Integrated genomic, functional, and prognostic characterization of atypical chronic myeloid leukemia	71
BCL2 in follicular lymphomas (FL): the overrated guy?	71
Correction to: Direct oral anticoagulants in patients with a left-sided bioprosthetic heart valve: a systematic review and meta‑analysis (Internal and Emergency Medicine, (2023), 18, 2, (535-547), 10.1007/s11739-023-03208-9)	70
A case of multicentric Castleman's disease mimicking non-Hodgkin lymphoma: when splenectomy is diagnostic and therapeutic	64
Direct oral anticoagulants in patients with a left-sided bioprosthetic heart valve: a systematic review and meta-analysis	64
Unnecessary use of proton pump inhibitors in patients discharged on oral anticoagulant therapy: data from the REPOSI registry	21
Impact of vitamin D plasma levels on in vitro natural killer cell cytotoxicity against non-small cell lung carcinoma in the presence of nivolumab	19
Idiopathic splanchnic vein thrombosis unmasking a clonal autoinflammatory disease	16
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry	10
Totale	13.710

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	60.511
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	60.511

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	781	0	98	40	55	35	106	33	30	53	171	64	96
2022/2023	1.253	130	86	90	128	101	234	1	189	186	37	36	35
2023/2024	1.724	263	260	244	319	303	159	16	27	62	30	17	24
2024/2025	1.369	25	25	252	40	55	75	63	95	148	122	122	347
2025/2026	3.652	294	250	236	504	337	234	644	199	382	248	208	116
2026/2027	249	89	160	0	0	0	0	0	0	0	0	0	0
Totale													13.710